Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Further validation of the Multiple Sclerosis Self-Efficacy Scale.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Disease modification in multiple sclerosis: an update.
Glutathione Homeostasis Disruption of Erythrocytes, but Not Glutathione Peroxidase Activity Change, Is Closely Accompanied with Neurological and Radiological Scoring of Acute CNS Inflammation.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Discovery of novel disease-specific and membrane-associated markers in a mouse model of multiple sclerosis.
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
Structural brain lesions in inflammatory bowel disease.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis.
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Dynamics of oligodendrocyte generation and myelination in the human brain.
MCAM(+) CD8 T lymphocytes mediate CNS inflammation.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »